🇺🇸 FDA
Pipeline program

Budesonide/formoterol

SF2016-1-4071

Unknown small_molecule completed

Quick answer

Budesonide/formoterol for COPD Exacerbation is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
COPD Exacerbation
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials